UNITED
STATES SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): November 15,
2010
TIENS
BIOTECH GROUP (USA), INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
001-32477
|
|
75-2926439
|
(State or other
jurisdiction
|
|
(Commission File
Number)
|
|
(I.R.S.
Employer
|
of
incorporation)
|
|
|
|
Identification
Number)
|
No. 17, Xinyuan Rd., Wuqing
New Tech Industrial Park, Tianjin, China 301700
(Address
of principal executive offices)
Registrant’s
telephone number, including area code:
(86)-22-8213-7914
No. 6, Yuanquan Rd., Wuqing
New Tech Industrial Park, Tianjin, China
301700
(Former
name or former address, if changed since last report.)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2.):
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
¨
|
Soliciting
materials pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item 2.02 Results of Operations and Financial
Condition.
On
November 15, 2010, Tiens Biotech Group (USA), Inc. (the “Company”) issued a
press release reporting the Company’s financial results for the fiscal quarter
ended September 30, 2010. The full text of the press release is set
forth in Exhibit 99.1 attached hereto.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits
.
Exhibit Number
|
|
Description
|
|
|
|
99.1
|
|
Press
release, dated November 15,
2010.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
TIENS
BIOTECH GROUP (USA), INC.
|
|
|
|
Date: November
16, 2010
|
By:
|
/s/ Jinyuan Li
|
|
|
Name: Jinyuan
Li
|
|
|
Title: Chief
Executive Officer
|
Exhibits
Exhibit Number
|
|
Description
|
|
|
|
99.1
|
|
Press
release, dated November 15,
2010.
|